晚期青光眼治疗研究(TAGS)参与者基线特征:多中心随机对照试验
TAGS是一项在多中心开展的实用性随机对照试验,纳入至少一眼新诊断晚期开角型青光眼(HPA分级严重视野缺损)的患者,随机分配接受初次增强小梁切除术或初次药物治疗。共招募453例患者,指标眼平均视野MD为-15.0 dB±6.3,非指标眼为-6.2 dB,指标眼LogMAR视力均值0.2±0.3。该研究旨在比较晚期青光眼药物与手术治疗的临床、生活质量和经济学结局。
要点
- TAGS纳入至少一眼HPA分级严重视野缺损的新诊断晚期开角型青光眼患者。
- 共453例患者,指标眼平均视野MD为-15.0 dB±6.3,非指标眼为-6.2 dB。
- 指标眼中超过70%基线MD<-12.00 dB,近90%在1%水平有超过20个视野点缺损。
核心结论
- TAGS是首个在公共资助医疗体系中比较晚期开角型青光眼药物与手术治疗随机对照试验。
- 该研究将提供临床、健康相关生活质量和经济学结局,以指导晚期青光眼患者的治疗选择。
研究设计与样本
- 实用性随机对照试验(RCT),多中心招募至少一眼新诊断晚期开角型青光眼患者。
- 纳入标准为开角型青光眼且至少一眼符合HPA标准严重视野缺损。
- 随机分配接受初次增强小梁切除术或初次药物治疗;双眼符合条件时双眼接受同一干预,分析指标眼取视野MD较轻的眼。
主要发现
- 共招募453例患者,指标眼平均视野MD为-15.0 dB±6.3,非指标眼为-6.2 dB。
- 指标眼(HPA严重分类)中超过70%基线MD<-12.00 dB,近90%在1%水平有超过20个视野点缺损。
- 指标眼平均LogMAR视力为0.2±0.3。
关键数值与推荐
- 晚期青光眼定义采用HPA标准严重视野缺损。
- 主要结局测量包括HPA分类的视野轮廓、临床特征以及VFQ-25、EQ-5D 5L、HUI-3和GPI生活质量量表。
临床怎么用
- 为晚期开角型青光眼患者选择初始药物或手术治疗提供随机对照证据。
- 基线数据显示纳入患者视野缺损严重,指标眼平均MD达-15.0 dB。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the baseline characteristics of participants enrolled in TAGS (Treatment of Advanced Glaucoma Study). DESIGN: Pragmatic randomized control trial (RCT). METHODS: Participants with newly diagnosed advanced glaucoma in at least 1 eye were recruited. Participants were patients with open angle glaucoma presenting with advanced glaucoma in at least 1 eye as defined by the Hodapp-Parrish-Anderson (HPA) criteria for severe defect. Participants were randomly allocated to receive either primary augmented trabeculectomy or primary medical management. When both eyes were eligible, the same intervention was undertaken in both eyes, and the index eye for analysis was the eye with the less severe visual field mean defect (MD). Main outcome measurements were visual field profile, defined by the HPA classification; clinical characteristics; quality of life, as measured by the National Eye Institute Visual Function Questionnaire 25 (VFQ-25), the EuroQual-5 Dimension (EQ-5D 5L), Health Utility Index-3 (HUI-3), and the Glaucoma Profile Instrument (GPI). RESULTS: A total of 453 patients were recruited. The mean visual field MD was -15.0 dB ± 6.3 in the index eye and -6.2 dB in the non-index eye. Of index eyes (HPA "severe" classification) at baseline, more than 70% of participants had a MD <-12.00 dB, and nearly 90% had more than 20 points defective at the 1% level. The mean LogMAR visual acuity of the index eye was 0.2 ± 0.3. CONCLUSIONS: TAGS is the first RCT to compare medical versus surgical treatments for patients presenting with advanced open angle glaucoma in a publicly funded health service. The study will provide clinical, health-related quality of life, and economic outcomes to inform future treatment choices for those presenting with advanced glaucoma.
引用
- King AJ, Hudson J, Fernie G, et al. Baseline Characteristics of Participants in the Treatment of Advanced Glaucoma Study: A Multicenter Randomized Controlled Trial. Am J Ophthalmol. 2020. PMID: 32006484. doi:10.1016/j.ajo.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。